Pharmacovigilance and Adverse Drug Reaction (ADRs)
Pharmacovigilance is highly dependent on the review of safety data collected from spontaneously reporting systems (SRSs) for adverse drug reaction (ADRs) submitted to regulatory authorities by healthcare professionals. Quantitative data mining procedures were used to analyze the drug safety data collected from SRSs to identify associated combination of drug-ADR products. Research suggests, however, that data collected from SRSs are limited due to incomplete or inaccurate clinical knowledge, underreporting, and bias reporting.But in the recent years that additional sources of safety information such as clinical trials, scientific literature and other epidemiology databases are established, valuable complementary sources of safety information, and can therefore help to reduce the effect of ADRs on public health
Need Help:
Uk: +44- 7424810299 Email: [email protected] Whatsapp: +91 9884350006










